Lessons From My 30 Years of Snakebite Management

Authors

  • Patel DC Director, Shri Sainath Hospital, Dharampur, Gujarat
  • Sovani VB Founder Director, Pharmawisdom.

DOI:

https://doi.org/10.37506/a4x0ak53

Keywords:

Russell’s viper, Saw scaled viper, Cobra, Krait, envenomation, haemotoxic, neurotoxic, anti-snake venom serum.

Abstract

Inspite of various guidelines for snakebite management, in real life, every case of snakebite poses a unique challenge and one may not always be able to abide strictly by the guidelines. There are a just a handful of physicians who are experts in managing snakebite. This article has been written by Dr D C Patel in Dharampur, Gujarat who has been treating snakebite victims for more than 30 years. This short communication draws on over three decades of clinical data and practice-based insights, offering guidance for public health professionals and community medicine practitioners in remote, resource-constrained settings. Data from April 1993 to March 2024 has been presented along with tips on snakebite management. His analysis presents a few insights- Russell’s viper bites have increased steeply over the years in Dharampur area and Valsad district of Gujarat. The mean number of vials used to manage bites by various species have fallen over time. Regular public awareness programshave borne fruit. Fewer patients visit faith healers and they reach the hospital quickly. Management of cases using the syndromic approach, early and adequate administration of clinically estimated amount of AVS along with organ support is the essential triad of management.

Author Biographies

  • Patel DC, Director, Shri Sainath Hospital, Dharampur, Gujarat

    Director, Shri Sainath Hospital, Dharampur, Gujarat

  • Sovani VB, Founder Director, Pharmawisdom.

    Founder Director, Pharmawisdom

References

1. Guidelines for management of Snakebites, New Delhi,

WHO Regional Office for South East Asia,2016

2. Standard Treatment Guidelines, Management of

Snakebites. Ministry of Health and Family Welfare.

January 2016

3. https://www.censusindia2011.com/gujarat/valsad/

dharampur-population.html Downloaded in April

2026

4. https://india.mongabay.com/2025/10/indiassnakes-

changing-range-thanks-to-climate-change/

Downloaded in April 2026

5. Abedin I, Kang H-E, Saikia H, Jung W-K, Kim H-W,

Kundu S (2025) Future of snakebite risk in India:

Consequence of climate change and the shifting

habitats of the big four species in next five decades.

PLoS Negl Trop Dis 19(9): e0013464. https://doi.

org/10.1371/ journal.pntd.0013464

6. Amin MR, Mamun SMH, Rashid R et al. Antisnake

Venom: Use and adverse reactions in a snake bite

study clinic in Bangladesh. J. Venom. Anim. Toxins

incl. Trop. Dis. 2008; 14:660-672

7. N Suchithra, J M Pappachan, P Sujathan.Snakebite

envenoming in Kerala, South India: clinical profile

and factors involved in adverse outcomesEmerg Med

J 2008;25:200–204

8. Bhattacharya P, Chakroborty A. Neurotoxicsnakebite

with respiratory failure. Indian J Crit CareMed 2007;

11:161

9. Sudeep Kumar , Sovani VB ,BhogeDP

,Postmarketingsafety and usage study of anti-snake

venom in atertiary hospital in Talegaon, Maharashtra,

Global J ofMed. And Pub. Health (GJMPH), 2019; 8:4,1

10. Ramesh J, Sovani VB, Baskeran R, Sivasankari N,

ArunR, Efficacy and Safety of Anti Snake Venom,

used asper National Guidelines, at a Tertiary Care

Centre inPuducherry, Indian J of Pub. Health Res. and

Dev.2020; 11:220

11. JC Menon, JK Joseph, MP Jose, BL Dhananjaya,

OVOommen, Clinical Profile and Laboratory

Parametersin1051 Victims of Snakebite from a Single

Centre inKerala, South India; Journal of Association

ofPhysicians of India,2016;64:22

12. Patel DC, Sovani VB, Patel NJ. Post Marketing

evaluation of Anti Snake Venom (ASV) administered

as a standard treatment for snakebite. Experience

from western India. Indian Journal of Public Health

Research and Development .2024;15:278-285

13. Suchaya Sanhajariya , Stephen B. Duffull , Geoffrey

K. Isbister, Pharmacokinetics of Snake Venom, Toxins

2018, 10: 73; doi:10.3390/toxins10020073

14. WHO Guidelines for the prevention and Clinical

management of snakebite in Africa. Regional office for

Africa, Brazzaville, 2010

15. PrasarnpunS, Walsh J, Awad SS , Harris JB.

Envenoming bites by kraits: the biological basis of

treatment-resistant neuromuscular paralysis. Brain

(2005), 128: 2987–2996

16. Blessmann J, Kreuels B Urgent administration of

antivenom following proven krait bites in Southeast

Asia irrespective of neurotoxic symptoms. PLoS

Negl Trop Dis (2024) 18(4): e0012079. https://doi.

org/10.1371/journal.pntd.0012079

17. Kularatne SAM Common krait (Bungarus caeruleus)

bite in Anuradhapura, Sri Lanka: a prospective clinical

study,1996–98, Postgrad Med J (2002);78:276–280

18. Indunil Karunarathna, Kapila De Alvis1, S Rajapaksha1,

K Gunawardana1, P Aluthge1, T Hapuarachchi1,

Pathophysiology of Russell’s Viper Venom and Its

Clinical Implications, UVA CLINICAL INTENSIVE

CARE AND TROPICAL MEDICINE 2024; 1-7 DOI:

10.13140/RG.2.2.19907.62246.

Downloads

Published

2026-06-29

How to Cite

Lessons From My 30 Years of Snakebite Management. (2026). Indian Journal of Public Health Research & Development, 17(3), 40-45. https://doi.org/10.37506/a4x0ak53